SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-22-008415
Filing Date
2022-12-22
Accepted
2022-12-22 16:04:30
Documents
2
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1703
2 SEMIGRAN POA semigran-poa2.txt EX-24 2007
  Complete submission text file 0001562180-22-008415.txt   5062
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Semigran Marc (Reporting) CIK: 0001691494 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40236 | Film No.: 221481988

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations